news
First-in-class therapy approved for schizophrenia
The “landmark” approval represents the first new class of medicine…
The “landmark” approval represents the first new class of medicine in several decades for treating schizophrenia.
List view / Grid view
Dr Tiffany Farchione
news
FDA publishes recommendations on psychedelic clinical trial design
New draft guidance published by the US Food and Drug…
New draft guidance published by the US Food and Drug Administration (FDA) is intended to aid clinical study design in psychedelic drug development programmes.
